07.01.2013 Views

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

Sorted By Test Name - Mayo Medical Laboratories

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

BRM<br />

8608<br />

BRUGM<br />

89476<br />

0 Negative<br />

1 0.35-0.69 Equivocal<br />

2 0.70-3.49 Positive<br />

3 3.50-17.4 Positive<br />

4 17.5-49.9 Strongly positive<br />

5 50.0-99.9 Strongly positive<br />

6 > or =100 Strongly positive Reference values<br />

apply to all ages.<br />

Clinical References: Homburger HA: Allergic diseases. In Clinical Diagnosis and Management by<br />

Laboratory Methods. 21st edition. Edited by McPherson RA, Pincus MR. WB Saunders, Publ, New York,<br />

Chapter 53, Part VI, pp. 961-971, 2007<br />

Bromide, Blood<br />

Clinical Information: Bromides are ingested principally as sedatives. They are used outside the<br />

United States to treat grand mal and focal epilepsy. Bromide shares the same volume of distribution as<br />

chloride, competes with chloride for renal excretion, and has a blood half-life of 12 to 15 days. Signs of<br />

acute toxicity include nausea, vomiting, and diarrhea. Manifestations of chronic toxicity can include<br />

lethargy, fatigue, irritability, loss of appetite, tachypnea, skin pigmentation, hallucinations, ataxia, and<br />

coma.<br />

Useful For: Assessing possible toxicity<br />

Interpretation: Therapeutic concentration: 1,000-2,000 mcg/mL Toxic concentration: > or =3,000<br />

mcg/mL<br />

Reference Values:<br />

Therapeutic concentration: 1,000-2,000 mcg/mL<br />

Toxic concentration: > or =3,000 mcg/mL<br />

NIH Unit<br />

Therapeutic concentration: 12.5-25.0 mmol/L<br />

Toxic concentration: >27.5 mmol/L<br />

Clinical References: Bowers GN Jr, Onoroski M: Hyperchloremia and the incidence of bromism in<br />

1990 (editorial). Clin Chem 1990;36:1399-1403<br />

Brucella Antibody Screen, IgG & IgM, Serum<br />

Clinical Information: Worldwide, brucellosis remains a major disease in humans and domesticated<br />

animals. Brucella infects goats (Brucella melitensis), cattle (Brucella abortus), swine (Brucella suis), and<br />

dogs (Brucella canis).(1) The disease has a limited geographic distribution. Few cases occur in the United<br />

States, with the bulk occurring in the Mediterranean region, Western Asia, and parts of Latin America and<br />

Africa. Three species of Brucella commonly cause disease in humans: Brucella melitensis, Brucella suis,<br />

and Brucella abortus. The acute disease often presents with fever, chills, and malaise; the chronic form<br />

also causes abscesses in bone, brain, spleen, liver, and kidney.<br />

Useful For: Evaluating patients with suspected brucellosis<br />

Interpretation: In the acute stage of the disease there is an initial production of IgM antibodies,<br />

followed closely by production of IgG antibodies. IgG-class antibodies may decline after treatment;<br />

however, high levels of circulating IgG-class antibodies may be found without any active disease. Chronic<br />

Current as of January 4, 2013 7:15 pm CST 800-533-1710 or 507-266-5700 or <strong>Mayo</strong><strong>Medical</strong><strong>Laboratories</strong>.com Page 296

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!